Effectiveness of the Cytokine Hemadsorption on Sepsis

Interleukin-6 Clinical Trial

Official title:
Effectiveness of the Cytokine Hemadsorption on the Clinical Progression and Mortality of Intensive Care Patients With Sepsis

Status Completed

Clinical Trial Summary

In this prospective study, we aimed to compare the laboratory and clinical results of cytokine hemadsorption as an immunomodulation therapy in ICU patients diagnosed with sepsis or septic shock.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05057455
Study type	Observational
Source	Biruni University
Contact
Status	Completed
Phase
Start date	January 1, 2020
Completion date	February 15, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04544254` - Effectivity of Bilateral Transversus Thoracis Muscle Plane Block After Open Heart Surgery	N/A
Recruiting	`NCT05867524` - Characterization of Natural IL-6 Inhibition in Healthy Individuals	N/A
Completed	`NCT03203343` - Inflammatory Stress Response in Pediatric Inguinal Hernia Repair	N/A
Recruiting	`NCT06238024` - Effect of Interleukin-6 Receptor Inhibition in Patients With Ischemic Stroke Undergoing Endovascular Treatment	Phase 2/Phase 3
Completed	`NCT05750160` - Music Therapy on Neutrophyl Lymphocytes Ratio, Interleukin 6 and Interleukin 10 Levels of Burnout Syndrome	N/A